Gene expression and TCR amino acid sequences selected by HLA‐A02:01‐restricted CTLs specific to HTLV‐1 in ATL patients

Author:

Kusuda Machiko1ORCID,Nakasone Hideki12ORCID,Yoshimura Kazuki1,Okada Yosuke1,Tamaki Masaharu1,Matsuoka Akari1,Ishikawa Takuto1,Meno Tomohiro1,Nakamura Yuhei1,Kawamura Masakatsu1,Takeshita Junko1,Kawamura Shunto1,Yoshino Nozomu1,Misaki Yukiko1ORCID,Gomyo Ayumi1,Tanihara Aki1,Kimura Shun‐ichi1ORCID,Kako Shinichi1ORCID,Kanda Yoshinobu1ORCID

Affiliation:

1. Division of Hematology Jichi Medical University Saitama Medical Center Saitama Japan

2. Division of Stem Cell Regulation Center for Molecular Medicine, Jichi Medicial University Shimotsuke Japan

Abstract

SummaryAdult T‐cell leukaemia/lymphoma (ATL) is an aggressive malignancy of peripheral T cells caused by human T‐cell lymphotropic virus type‐1 (HTLV‐1). Tax is the most important regulatory protein for HTLV‐1. We aimed to reveal a unique amino acid sequence (AA) of complementarity‐determining region 3 (CDR3) of the T‐cell receptor (TCR)β and TCRα chains of HLA‐A*02:01‐restricted Tax11–19‐specific cytotoxic T cells (Tax‐CTLs). The gene expression profiles (GEP) of Tax‐CTLs were assessed by the next‐generation sequence (NGS) method with SMARTer technology. Tax‐CTLs seemed to be oligoclonal, and their gene compositions were skewed. The unique motifs of ‘DSWGK’ in TCRα and ‘LAG’ in TCRβ at CDR3 were observed in almost all patients. Tax‐CTL clones harbouring the ‘LAG’ motif with BV28 had a higher binding score than those without either of them, besides a higher binding score associated with longer survival. Tax‐CTLs established from a single cell showed killing activities against Tax‐peptide‐pulsed HLA‐A2+ T2 cell lines. GEP of Tax‐CTLs revealed that genes associated with immune response activity were well preserved in long‐term survivors with stable status. These methods and results can help us better understand immunity against ATL, and should contribute to future studies on the clinical application of adoptive T‐cell therapies.

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Hematology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3